Despite the fact that the duration of diabetes was basically twice as long in patients of the T2DM group, a greater number of diabetic complications were present, and a more significant proportion of patients required (intensive) insulin therapy, no significant effect could be justified for any of the above-mentioned parameters. This evidence concerns the gene INS and diabetes mellitus.